The combination of a SPHK1 inhibitor named SKI-II or SPHK1 knockdown with curcumin has shown promising effects in enhancing growth inhibition and inducing apoptosis in ovarian cancer cells [32]. Here, SPHK1 is linked to ovarian cancer.